Profiles

Keywords
Last Name
Institution

Ajaypal Singh

Concepts (481)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anemia
49
2019
89
14.710
Why?
Hematinics
38
2018
40
12.190
Why?
Erythropoietin
36
2019
46
9.840
Why?
Kidney Failure, Chronic
31
2019
161
8.850
Why?
Kidney Diseases
25
2017
141
8.300
Why?
Hemoglobins
34
2017
76
7.710
Why?
Renal Insufficiency, Chronic
24
2019
81
7.530
Why?
Renal Dialysis
30
2018
96
6.480
Why?
Tomography, X-Ray Computed
26
2019
814
5.550
Why?
Blast Injuries
5
2016
7
2.930
Why?
Humans
136
2019
26370
2.830
Why?
Kidney
10
2016
187
2.770
Why?
Randomized Controlled Trials as Topic
9
2013
306
2.190
Why?
Terrorism
5
2016
15
1.850
Why?
Middle Aged
60
2019
9914
1.820
Why?
Recombinant Proteins
20
2013
293
1.760
Why?
Male
72
2019
15333
1.710
Why?
Anemia, Iron-Deficiency
4
2015
5
1.700
Why?
Female
71
2019
15699
1.610
Why?
Foreign Bodies
3
2015
23
1.510
Why?
Cardiovascular Diseases
13
2019
311
1.510
Why?
Mass Screening
3
2014
167
1.500
Why?
Heart Failure
10
2019
185
1.490
Why?
Magnetic Resonance Imaging
7
2018
1103
1.460
Why?
Diabetes Mellitus, Type 2
11
2019
193
1.450
Why?
Aged
48
2019
8724
1.420
Why?
Adult
38
2018
8641
1.410
Why?
Chronic Disease
16
2010
476
1.400
Why?
Nephrology
3
2016
15
1.310
Why?
Lupus Nephritis
4
2006
30
1.300
Why?
Diabetic Nephropathies
6
2019
38
1.280
Why?
Biopsy, Needle
3
2012
114
1.270
Why?
Multiple Trauma
4
2016
5
1.240
Why?
Risk Factors
22
2019
2272
1.190
Why?
Kidney Transplantation
5
2009
121
1.170
Why?
Bone Diseases, Metabolic
3
2016
15
1.080
Why?
Liver Transplantation
3
2015
96
1.060
Why?
Vitamin D
3
2013
17
1.040
Why?
Colitis
3
2005
28
1.020
Why?
Prevalence
10
2016
488
0.990
Why?
United States Food and Drug Administration
3
2010
73
0.950
Why?
Prolyl-Hydroxylase Inhibitors
1
2019
1
0.950
Why?
Prognosis
9
2017
874
0.940
Why?
Practice Guidelines as Topic
8
2012
346
0.930
Why?
Treatment Outcome
21
2018
3306
0.910
Why?
Glomerular Filtration Rate
8
2016
72
0.880
Why?
Hypertension
5
2017
215
0.860
Why?
Iron
3
2015
16
0.860
Why?
Acute Kidney Injury
3
2014
47
0.850
Why?
Fasciitis, Necrotizing
1
2018
2
0.850
Why?
Lower Extremity
1
2018
36
0.820
Why?
Ferric Compounds
4
2015
6
0.820
Why?
Retrospective Studies
16
2019
2701
0.790
Why?
Marijuana Smoking
1
2017
5
0.790
Why?
Head Injuries, Penetrating
1
2017
1
0.780
Why?
Boston
6
2016
22
0.780
Why?
Wounds, Gunshot
1
2017
6
0.780
Why?
Ferritins
5
2017
9
0.760
Why?
Blood Glucose
1
2017
118
0.760
Why?
Risk Assessment
11
2019
709
0.740
Why?
Pathology
1
2016
4
0.740
Why?
Cytokines
2
2008
334
0.730
Why?
Contrast Media
6
2019
143
0.720
Why?
Evidence-Based Medicine
4
2010
211
0.710
Why?
Biliary Fistula
2
2006
5
0.710
Why?
Abdominal Injuries
1
2015
6
0.710
Why?
Renal Replacement Therapy
2
2015
19
0.710
Why?
Triage
1
2016
24
0.710
Why?
Proteinuria
4
2013
111
0.700
Why?
Pelvis
1
2015
25
0.700
Why?
Certification
1
2016
53
0.700
Why?
Saudi Arabia
6
2016
7
0.700
Why?
Neck Injuries
1
2015
4
0.690
Why?
Medicare
4
2010
80
0.690
Why?
Adolescent
12
2016
2363
0.690
Why?
Craniocerebral Trauma
1
2015
12
0.690
Why?
Education, Medical, Graduate
1
2016
67
0.680
Why?
Consanguinity
2
2014
4
0.670
Why?
Radiography, Interventional
3
2012
25
0.650
Why?
Diagnosis, Differential
10
2019
446
0.650
Why?
Hypertension, Renal
1
2014
4
0.640
Why?
United States
11
2017
2083
0.640
Why?
Societies, Medical
1
2016
183
0.640
Why?
Diagnostic Imaging
1
2015
92
0.630
Why?
Ventricular Fibrillation
1
2014
23
0.630
Why?
Death, Sudden, Cardiac
1
2014
23
0.620
Why?
Cost of Illness
1
2014
53
0.610
Why?
Acute Disease
6
2017
258
0.610
Why?
Vitamin D Deficiency
1
2013
12
0.610
Why?
Heart Arrest
1
2014
47
0.600
Why?
Pediatrics
1
2013
53
0.580
Why?
Research Design
4
2008
186
0.570
Why?
Biomedical Research
1
2013
80
0.570
Why?
Platelet Activation
1
2012
3
0.560
Why?
Kidney Tubules
2
2009
13
0.560
Why?
Tissue Donors
3
2015
54
0.560
Why?
Splenic Diseases
1
2012
3
0.560
Why?
Disease Outbreaks
1
2012
88
0.550
Why?
Blood Platelets
1
2012
51
0.550
Why?
Spleen
1
2012
53
0.550
Why?
Organotechnetium Compounds
2
2008
11
0.540
Why?
Abdomen, Acute
3
2008
5
0.540
Why?
Ciprofloxacin
2
2008
33
0.540
Why?
Fanconi Syndrome
1
2011
1
0.540
Why?
Injections, Subcutaneous
3
2010
38
0.540
Why?
Red-Cell Aplasia, Pure
2
2008
2
0.540
Why?
Child
7
2016
1375
0.530
Why?
Appendicitis
2
2008
10
0.530
Why?
Multiple Myeloma
1
2011
27
0.520
Why?
Mass Casualty Incidents
3
2016
6
0.520
Why?
Stroke
7
2019
306
0.520
Why?
Surgery, Computer-Assisted
1
2012
57
0.520
Why?
Bombs
3
2015
3
0.510
Why?
Liver
2
2015
202
0.490
Why?
Preoperative Care
4
2015
132
0.490
Why?
Biliary Tract Diseases
1
2010
7
0.480
Why?
Reimbursement Mechanisms
1
2010
13
0.480
Why?
Drug Approval
1
2010
34
0.480
Why?
Vascular Diseases
1
2010
43
0.470
Why?
Liver Diseases
1
2010
38
0.460
Why?
Calcium Compounds
1
2009
2
0.450
Why?
Early Diagnosis
4
2014
67
0.450
Why?
Minerals
1
2009
7
0.450
Why?
Inflammation
2
2008
296
0.450
Why?
Medicine, Traditional
1
2008
1
0.450
Why?
Bone Density Conservation Agents
1
2009
12
0.450
Why?
Aged, 80 and over
11
2017
4444
0.440
Why?
Predictive Value of Tests
7
2016
573
0.440
Why?
Bone Diseases, Infectious
1
2008
3
0.440
Why?
Needles
1
2008
15
0.440
Why?
Abdominal Muscles
1
2008
6
0.430
Why?
Muscle Neoplasms
1
2008
5
0.430
Why?
Cost Savings
1
2008
33
0.430
Why?
Phosphates
1
2008
15
0.430
Why?
Pelvic Pain
1
2008
11
0.430
Why?
Kidney Glomerulus
1
2009
82
0.420
Why?
Immunologic Factors
1
2008
42
0.420
Why?
Data Interpretation, Statistical
1
2008
94
0.420
Why?
Acute Coronary Syndrome
1
2008
12
0.420
Why?
India
3
2014
20
0.420
Why?
Bacterial Infections
1
2008
69
0.420
Why?
Nephritis, Interstitial
2
2008
6
0.420
Why?
Calculi
1
2008
3
0.420
Why?
Endothelium, Vascular
1
2008
70
0.420
Why?
Abdominal Abscess
1
2008
5
0.420
Why?
Appendectomy
1
2008
10
0.420
Why?
Endoscopy
1
2010
161
0.420
Why?
Dose-Response Relationship, Drug
5
2013
506
0.420
Why?
Hospital Mortality
2
2014
141
0.420
Why?
Bone and Bones
1
2009
106
0.420
Why?
Glomerulosclerosis, Focal Segmental
1
2009
82
0.410
Why?
Cholangiopancreatography, Magnetic Resonance
2
2019
4
0.410
Why?
Multicenter Studies as Topic
2
2007
64
0.410
Why?
Diabetic Angiopathies
2
2019
8
0.400
Why?
Carcinoma, Renal Cell
1
2008
75
0.400
Why?
Myocardial Infarction
3
2017
171
0.400
Why?
Pancreatic Fistula
1
2006
2
0.390
Why?
Ascites
1
2006
5
0.390
Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
32
0.390
Why?
Neoplasms
2
2009
230
0.380
Why?
Diabetes Complications
1
2007
56
0.380
Why?
Algorithms
4
2016
378
0.370
Why?
Tissue and Organ Procurement
1
2006
30
0.370
Why?
Clinical Trials as Topic
1
2008
368
0.370
Why?
Erythropoiesis
2
2019
4
0.360
Why?
Penile Neoplasms
1
2005
4
0.360
Why?
Hernia, Abdominal
1
2005
2
0.350
Why?
Iron Compounds
1
2005
2
0.340
Why?
Metabolic Diseases
1
2005
14
0.340
Why?
Cross-Sectional Studies
5
2013
777
0.330
Why?
Cohort Studies
7
2014
1601
0.330
Why?
Infertility
1
2004
2
0.320
Why?
Fertility
1
2004
10
0.320
Why?
Intestinal Fistula
1
2004
9
0.320
Why?
Testis
1
2004
11
0.320
Why?
Colonic Diseases
1
2004
15
0.320
Why?
Gallbladder Diseases
1
2004
7
0.320
Why?
Mesenteric Vascular Occlusion
1
2004
4
0.320
Why?
Infarction
1
2004
6
0.320
Why?
Pancreaticoduodenectomy
1
2004
36
0.320
Why?
Cyclophosphamide
1
2004
57
0.320
Why?
Omentum
1
2004
9
0.320
Why?
Glomerulonephritis
1
2004
25
0.320
Why?
Immunosuppressive Agents
2
2009
147
0.320
Why?
Severity of Illness Index
5
2012
1134
0.320
Why?
Immunosuppression
1
2004
38
0.320
Why?
Ovary
1
2004
26
0.320
Why?
Biopsy
4
2011
267
0.320
Why?
Radiographic Image Enhancement
1
2004
15
0.310
Why?
Granuloma
1
2003
14
0.310
Why?
Ibuprofen
1
2003
11
0.310
Why?
Cholelithiasis
1
2003
10
0.310
Why?
Gastric Outlet Obstruction
1
2003
5
0.310
Why?
Comorbidity
3
2013
481
0.300
Why?
Young Adult
5
2017
1890
0.300
Why?
Incidence
3
2017
699
0.300
Why?
Nurse's Role
1
2005
133
0.300
Why?
Hyperparathyroidism, Secondary
2
2016
4
0.300
Why?
Patient Education as Topic
3
2010
183
0.290
Why?
Survival Analysis
3
2009
363
0.280
Why?
Inflammatory Bowel Diseases
1
2004
84
0.280
Why?
Prospective Studies
7
2018
1562
0.270
Why?
Survival Rate
3
2014
403
0.270
Why?
Injections, Intravenous
4
2008
60
0.260
Why?
Confidence Intervals
3
2012
103
0.250
Why?
Models, Biological
1
2003
415
0.250
Why?
Disease Progression
4
2017
745
0.240
Why?
Child, Preschool
4
2016
746
0.240
Why?
Double-Blind Method
7
2018
513
0.240
Why?
Hypoxia-Inducible Factor-Proline Dioxygenases
1
2019
2
0.240
Why?
Mitochondrial Proteins
1
2019
38
0.230
Why?
Intracellular Signaling Peptides and Proteins
1
2019
51
0.230
Why?
Lupus Erythematosus, Systemic
1
2002
167
0.230
Why?
Choledocholithiasis
1
2019
2
0.230
Why?
Catheterization
2
2012
61
0.230
Why?
Drainage
2
2012
53
0.230
Why?
Hospitalization
4
2017
283
0.230
Why?
Administration, Oral
1
2019
152
0.230
Why?
Myositis
1
2019
20
0.230
Why?
C-Reactive Protein
2
2017
130
0.230
Why?
Deglutition Disorders
1
2019
45
0.230
Why?
Autoimmune Diseases
1
2019
52
0.220
Why?
Metformin
1
2019
15
0.220
Why?
Running
2
2016
20
0.220
Why?
Ultrasonography, Interventional
2
2012
64
0.220
Why?
Fractures, Closed
1
2018
2
0.220
Why?
Foot Injuries
1
2018
2
0.220
Why?
Leiomyoma
2
2008
9
0.210
Why?
Ankle Injuries
1
2018
11
0.210
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2019
66
0.210
Why?
Ultrasonography
2
2018
184
0.210
Why?
Drug Costs
2
2008
16
0.210
Why?
Up-Regulation
2
2010
189
0.210
Why?
Health Knowledge, Attitudes, Practice
2
2010
203
0.210
Why?
Biosimilar Pharmaceuticals
1
2017
1
0.210
Why?
Continental Population Groups
2
2009
96
0.200
Why?
Quality of Life
4
2017
525
0.200
Why?
Patient Selection
2
2010
235
0.200
Why?
Glasgow Coma Scale
1
2017
17
0.190
Why?
Antihypertensive Agents
1
2017
65
0.190
Why?
Emergency Service, Hospital
1
2019
141
0.190
Why?
Public Health
1
2017
47
0.190
Why?
Executive Function
2
2014
86
0.190
Why?
Follow-Up Studies
6
2014
1820
0.190
Why?
Blood Pressure
1
2017
206
0.190
Why?
Time Factors
4
2018
1713
0.190
Why?
Sensitivity and Specificity
5
2018
576
0.190
Why?
International Cooperation
1
2016
35
0.180
Why?
Explosions
1
2016
1
0.180
Why?
Pilot Projects
3
2017
391
0.180
Why?
Drug Monitoring
2
2006
25
0.180
Why?
Age Factors
3
2014
816
0.180
Why?
Muscle, Skeletal
1
2019
332
0.180
Why?
Program Development
1
2016
69
0.180
Why?
Diphosphates
1
2015
1
0.180
Why?
Dialysis Solutions
1
2015
5
0.180
Why?
Trauma Centers
1
2015
11
0.170
Why?
Radiography
1
2018
693
0.170
Why?
Radiopharmaceuticals
2
2007
56
0.170
Why?
Risk Reduction Behavior
3
2011
48
0.170
Why?
Cognition Disorders
2
2014
1029
0.170
Why?
Intensive Care Units, Pediatric
1
2014
13
0.170
Why?
Wounds, Penetrating
1
2014
8
0.170
Why?
Curriculum
1
2016
135
0.170
Why?
Corneal Opacity
1
2014
2
0.160
Why?
Acidosis, Renal Tubular
1
2014
2
0.160
Why?
Sex Factors
2
2013
459
0.160
Why?
Cardiopulmonary Resuscitation
1
2014
10
0.160
Why?
Electric Countershock
1
2014
20
0.160
Why?
Kidney Function Tests
2
2017
26
0.160
Why?
Pedigree
1
2013
69
0.150
Why?
Defibrillators, Implantable
1
2014
21
0.150
Why?
Blood Viscosity
1
2013
10
0.150
Why?
Kaplan-Meier Estimate
3
2012
197
0.150
Why?
Coronary Angiography
1
2014
88
0.150
Why?
Chi-Square Distribution
2
2010
176
0.150
Why?
Sex Distribution
1
2013
85
0.150
Why?
Critical Care
1
2016
194
0.150
Why?
Middle East
1
2012
5
0.150
Why?
Age Distribution
1
2013
116
0.150
Why?
Calcinosis
2
2014
47
0.140
Why?
Electrocardiography
1
2014
199
0.140
Why?
Cell-Derived Microparticles
1
2012
1
0.140
Why?
Regression Analysis
2
2012
302
0.140
Why?
P-Selectin
1
2012
3
0.140
Why?
CD40 Ligand
1
2012
9
0.140
Why?
Splenic Artery
1
2012
1
0.140
Why?
Sclerosing Solutions
1
2012
3
0.140
Why?
Sclerotherapy
1
2012
2
0.140
Why?
Pneumothorax
1
2012
11
0.140
Why?
Magnetic Resonance Imaging, Interventional
1
2012
8
0.140
Why?
Aneurysm, False
1
2012
13
0.140
Why?
Population Surveillance
1
2012
118
0.130
Why?
Radionuclide Imaging
2
2008
61
0.130
Why?
Postoperative Hemorrhage
1
2012
27
0.130
Why?
Osteomyelitis
2
2008
23
0.130
Why?
Catheter Ablation
1
2012
44
0.130
Why?
Thrombosis
2
2017
61
0.130
Why?
Microscopy, Electron
1
2011
99
0.130
Why?
Bone Marrow Transplantation
1
2011
43
0.130
Why?
Risk
2
2010
203
0.130
Why?
Drug Therapy, Combination
3
2008
251
0.130
Why?
Embolization, Therapeutic
1
2012
74
0.130
Why?
Multivariate Analysis
4
2015
356
0.120
Why?
Iron, Dietary
1
2010
1
0.120
Why?
Ferrosoferric Oxide
1
2010
1
0.120
Why?
Hepcidins
1
2010
1
0.120
Why?
Antimicrobial Cationic Peptides
1
2010
4
0.120
Why?
Indicators and Reagents
1
2010
19
0.120
Why?
Cardiac Output
1
2010
24
0.120
Why?
Hepatectomy
1
2011
58
0.120
Why?
Glomerulonephritis, Membranous
1
2010
8
0.120
Why?
Awareness
1
2010
46
0.120
Why?
Consumer Product Safety
1
2010
7
0.120
Why?
Ethanol
1
2012
119
0.120
Why?
Drug Labeling
1
2010
6
0.120
Why?
Case-Control Studies
2
2011
608
0.120
Why?
Immunohistochemistry
1
2011
467
0.120
Why?
Health Care Reform
1
2010
17
0.120
Why?
Erythrocytes
1
2009
30
0.120
Why?
Developing Countries
1
2009
26
0.120
Why?
Feasibility Studies
1
2010
217
0.120
Why?
Hematocrit
1
2009
15
0.120
Why?
Global Health
1
2009
51
0.110
Why?
Sirolimus
1
2009
16
0.110
Why?
Massachusetts
1
2009
20
0.110
Why?
Ergocalciferols
1
2009
2
0.110
Why?
Phosphorus
1
2009
7
0.110
Why?
Calcitriol
1
2009
6
0.110
Why?
Length of Stay
2
2014
305
0.110
Why?
Calcium
2
2016
481
0.110
Why?
Radioactive Tracers
1
2008
2
0.110
Why?
Tuberculosis, Osteoarticular
1
2008
3
0.110
Why?
Diabetic Foot
1
2008
4
0.110
Why?
Living Donors
1
2009
17
0.110
Why?
Cilazapril
1
2008
1
0.110
Why?
Glomerulonephritis, IGA
1
2008
5
0.110
Why?
Orthopedic Fixation Devices
1
2008
25
0.110
Why?
Ovarian Diseases
1
2008
1
0.110
Why?
Gadolinium
1
2008
16
0.110
Why?
Publication Bias
1
2008
8
0.110
Why?
Kidney Diseases, Cystic
1
2008
2
0.110
Why?
Radiography, Abdominal
1
2008
7
0.110
Why?
Leuprolide
1
2008
4
0.110
Why?
Menorrhagia
1
2008
5
0.110
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2008
28
0.110
Why?
Puerperal Disorders
1
2008
10
0.110
Why?
Diabetes Mellitus
1
2009
100
0.110
Why?
Reference Values
2
2013
250
0.110
Why?
Probability
1
2008
96
0.110
Why?
Renal Insufficiency
1
2008
18
0.110
Why?
Interleukin-8
1
2008
35
0.110
Why?
Polycythemia
1
2008
1
0.110
Why?
Fournier Gangrene
1
2008
2
0.110
Why?
Antineoplastic Agents
1
2011
292
0.110
Why?
Prednisone
1
2008
72
0.110
Why?
Antineoplastic Agents, Hormonal
1
2008
20
0.110
Why?
Medicaid
1
2008
38
0.110
Why?
Sclerosis
1
2008
50
0.110
Why?
Arteriovenous Shunt, Surgical
1
2008
12
0.100
Why?
Iatrogenic Disease
1
2008
20
0.100
Why?
Hypoglycemia
1
2008
17
0.100
Why?
Animals
2
2009
4859
0.100
Why?
Disorders of Excessive Somnolence
1
2008
17
0.100
Why?
Nephrectomy
1
2008
46
0.100
Why?
Pregnancy Complications
1
2008
48
0.100
Why?
Metabolic Clearance Rate
1
2007
8
0.100
Why?
Odds Ratio
1
2009
289
0.100
Why?
Half-Life
1
2007
16
0.100
Why?
Biological Availability
1
2007
24
0.100
Why?
Primary Prevention
1
2008
35
0.100
Why?
Periodicals as Topic
1
2008
37
0.100
Why?
Interleukin-6
1
2008
114
0.100
Why?
Graft Rejection
1
2008
86
0.100
Why?
Angioplasty, Balloon, Coronary
1
2008
54
0.100
Why?
Adrenal Cortex Hormones
1
2008
84
0.100
Why?
Clinical Competence
1
2010
244
0.100
Why?
Hematopoiesis
1
2007
14
0.100
Why?
Diffusion of Innovation
1
2007
37
0.100
Why?
Image Processing, Computer-Assisted
1
2008
225
0.100
Why?
Patient Dropouts
1
2007
31
0.100
Why?
Tuberculosis
1
2007
24
0.100
Why?
Bone Diseases
1
2007
23
0.100
Why?
Pregnancy
1
2008
372
0.100
Why?
Tumor Necrosis Factor-alpha
1
2008
228
0.100
Why?
Cardiac Catheterization
1
2008
103
0.100
Why?
Cause of Death
2
2019
62
0.100
Why?
Transplantation, Homologous
1
2008
258
0.100
Why?
Morbidity
1
2006
61
0.090
Why?
Fluoroscopy
1
2006
42
0.090
Why?
Proportional Hazards Models
3
2013
326
0.090
Why?
Anti-Bacterial Agents
1
2010
382
0.090
Why?
Mortality
2
2019
65
0.090
Why?
Inpatients
1
2008
106
0.090
Why?
Catheters, Indwelling
1
2006
29
0.090
Why?
Laparoscopy
1
2008
169
0.090
Why?
Graft Survival
1
2006
106
0.090
Why?
Cadaver
1
2006
329
0.080
Why?
Causality
1
2005
49
0.080
Why?
Histology
1
2004
4
0.080
Why?
Penis
1
2005
52
0.080
Why?
Infusions, Intravenous
1
2005
99
0.080
Why?
Evaluation Studies as Topic
1
2005
55
0.080
Why?
Patient Care Planning
1
2005
52
0.080
Why?
Melena
1
2004
1
0.080
Why?
Ovum
1
2004
5
0.080
Why?
Spermatozoa
1
2004
9
0.080
Why?
Mesenteric Artery, Superior
1
2004
5
0.080
Why?
Oocytes
1
2004
14
0.080
Why?
Embryo, Mammalian
1
2004
34
0.080
Why?
Cryopreservation
1
2004
21
0.080
Why?
Cell Transplantation
1
2004
28
0.080
Why?
Postoperative Complications
1
2012
962
0.080
Why?
Nephrosis
1
2003
5
0.080
Why?
Nephritis
1
2003
3
0.080
Why?
Iothalamic Acid
1
2003
2
0.080
Why?
Technetium Tc 99m Pentetate
1
2003
3
0.080
Why?
Iodine Radioisotopes
1
2003
24
0.080
Why?
Crohn Disease
1
2004
43
0.080
Why?
Syndrome
1
2003
107
0.080
Why?
Colitis, Ulcerative
1
2004
71
0.070
Why?
Nucleosomes
1
2002
4
0.070
Why?
Postoperative Period
1
2003
194
0.070
Why?
Autoantibodies
1
2002
99
0.070
Why?
Memory
2
2014
308
0.070
Why?
Apoptosis
1
2002
284
0.060
Why?
Myoglobinuria
1
2019
2
0.060
Why?
Rhabdomyolysis
1
2019
6
0.060
Why?
Carotid Artery, Internal
1
2019
25
0.060
Why?
Magnetic Resonance Angiography
1
2019
47
0.060
Why?
Muscle Weakness
1
2019
34
0.060
Why?
Creatinine
2
2009
55
0.060
Why?
Veins
1
2017
7
0.050
Why?
Systole
1
2017
22
0.050
Why?
Therapeutic Equivalency
1
2017
8
0.050
Why?
Longitudinal Studies
2
2014
1168
0.050
Why?
Hypotension
1
2017
29
0.050
Why?
Cerebral Infarction
1
2019
142
0.050
Why?
Arteries
1
2017
20
0.050
Why?
Hypertrophy, Left Ventricular
1
2017
28
0.050
Why?
Transferrin
2
2008
6
0.050
Why?
Anastomosis, Surgical
1
2017
55
0.050
Why?
Body Weight
1
2017
152
0.050
Why?
Patient Acuity
1
2016
9
0.050
Why?
Parathyroid Hormone
1
2016
23
0.040
Why?
Administration, Intravenous
1
2015
31
0.040
Why?
Cholesterol, HDL
1
2015
27
0.040
Why?
Triglycerides
1
2015
46
0.040
Why?
Cholesterol, LDL
1
2015
41
0.040
Why?
Image Enhancement
1
2015
70
0.040
Why?
Single-Blind Method
1
2015
122
0.040
Why?
Dietary Supplements
1
2015
54
0.040
Why?
Oliguria
1
2014
1
0.040
Why?
Burns, Chemical
1
2014
3
0.040
Why?
Diuretics
1
2014
13
0.040
Why?
Sodium-Bicarbonate Symporters
1
2014
1
0.040
Why?
Basal Ganglia Diseases
1
2014
11
0.040
Why?
Homozygote
1
2014
27
0.040
Why?
Sequence Deletion
1
2014
22
0.040
Why?
Imaging, Three-Dimensional
1
2015
204
0.040
Why?
Respiration, Artificial
1
2014
85
0.040
Why?
Recurrence
1
2014
344
0.040
Why?
Principal Component Analysis
1
2013
22
0.040
Why?
Sepsis
1
2014
142
0.040
Why?
Infant
1
2014
590
0.040
Why?
Mental Status Schedule
1
2013
123
0.040
Why?
Hemoglobinometry
1
2012
1
0.040
Why?
Linear Models
1
2013
256
0.030
Why?
Drug Delivery Systems
1
2012
39
0.030
Why?
Analysis of Variance
1
2012
364
0.030
Why?
Thailand
1
2009
14
0.030
Why?
Logistic Models
1
2011
453
0.030
Why?
Disease Management
1
2009
119
0.030
Why?
Drug Interactions
1
2008
68
0.030
Why?
Neuropsychological Tests
1
2013
1151
0.030
Why?
Health Expenditures
1
2007
14
0.030
Why?
False Positive Reactions
1
2007
40
0.020
Why?
Equipment Failure
1
2006
48
0.020
Why?
Costs and Cost Analysis
1
2006
37
0.020
Why?
Demography
1
2006
72
0.020
Why?
Ambulatory Care
1
2006
79
0.020
Why?
Singh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description